| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | 具有新的电子受体系统的杂环发色团结构 | CN200680001110.3 | 2006-03-30 | CN101068795A | 2007-11-07 | F·J·戈茨; F·J·小戈茨 |
| 式I形式的、用于产生一阶、二阶、三阶和/或更高阶的极化率的NLO发色团及其商业上可接受的盐、溶剂化物和水合物，其中n、p、X、Acc、Z1－4、Q1－5、π、D和A具有本文提供的定义。 | ||||||
| 2 | 具有HIV整合酶抑制活性的多环氨基甲酰基吡啶酮衍生物 | CN200680022891.4 | 2006-04-28 | CN101212903A | 2008-07-02 | B·A·约翰斯; 川筋孝; 大司照彦; 垰田善之 |
| 本发明提供新的如下所示的化合物(I)，其具有抗－病毒活性，特别是HIV整合酶抑制活性，及含有相同化合物的药物，特别是抗－HIV药物，以及其制备方法和中间体。化合物(I)，其中Z1为 NR4；R1为氢或低级烷基；X为单键、选自O、S、SO、SO2和NH的杂原子基团，或低级亚烷基或低级亚链烯基，其中杂原子基团可以被插入；R2为任选取代的芳基；R3为氢、卤素、羟基、任选取代的低级烷基等；及R4和Z2部分结合在一起形成环，形成多环化合物，包括如三环或四环化合物。 | ||||||
| 3 | 经杂芳基取代的喹啉-4-基氨类似物 | CN200680002257.4 | 2006-01-13 | CN101103028A | 2008-01-09 | T·M·考德威尔; B·谢纳尔; K·霍杰茨 |
| 提供通式I的经杂芳基取代的喹啉-4-基氨类似物：此等化合物为可用于活体内或活体外调节特定受体活性的配体，特别可用于治疗人类、驯化的伴侣动物、及牲口动物的与病理性受体活化相关联的疾病。提供使用此等化合物来治疗此等失调的医药组合物及方法，也提供使用此等配体于受体定位研究的方法。 | ||||||
| 4 | 杂环发色团结构 | CN200580036676.5 | 2005-10-26 | CN101080394A | 2007-11-28 | F·J·戈茨; F·J·小戈茨 |
| 式I的NLO发色团及其可接受的盐、溶剂化物和水合物，其中Z、X1－4、π1－2、D和A具有本文提供的定义。 | ||||||
| 5 | 蛋白激酶的抑制剂咪唑并[4,5－b]吡嗪酮 | CN200580040310.5 | 2005-09-23 | CN101065016A | 2007-10-31 | J·刘; R·J·佩奇; M·R·普莱尔 |
| 本发明涉及式(I)的化合物：其中Q、Y、A如说明书中所述，以及其溶剂合物、水合物、互变异构体或药学上可接受的盐，其抑制蛋白激酶，尤其是Aurora－1、Aurora－2和Aurora－3激酶。 | ||||||
| 6 | 具有整合酶抑制活性的吡啶酮化合物及其药用用途 | CN202280050796.4 | 2022-06-02 | CN117715908A | 2024-03-15 | 祝令建; 洪敏; 陶伟峰; 吴岱泽; 潘小玉; 高璐; 黄建 |
| 本公开提供具有整合酶抑制活性的吡啶酮化合物及其药用用途。具体而言，本公开提供式I所示的化合物结构或其可药用盐，可用于治疗人类免疫缺陷(HIV)感染。 | ||||||
| 7 | 具有HIV整合酶抑制活性的多环氨基甲酰基吡啶酮衍生物 | CN200680022891.4 | 2006-04-28 | CN101212903B | 2013-07-24 | B·A·约翰斯; 川筋孝; 大司照彦; 垰田善之 |
| 本发明提供新的如下所示的化合物(I)，其具有抗-病毒活性，特别是HIV整合酶抑制活性，及含有相同化合物的药物，特别是抗-HIV药物，以及其制备方法和中间体。化合物(I)，其中Z1 is NR4；R1为氢或低级烷基；X为单键、选自O、S、SO、SO2和NH的杂原子基团，或低级亚烷基或低级亚链烯基，其中杂原子基团可以被插入；R2为任选取代的芳基；R3为氢、卤素、羟基、任选取代的低级烷基等；及R4和Z2部分结合在一起形成环，形成多环化合物，包括如三环或四环化合物。 | ||||||
| 8 | 制备2，2’-二(3，4-亚乙二氧基噻吩) | CN200310122577.1 | 2003-12-10 | CN100506824C | 2009-07-01 | K·鲁特 |
| 本发明涉及制备通式(I)所示化合物的方法、这类物质的新颖化合物，还涉及它们作为重要前体或者用于制备π-共轭聚合物用的重要前体的应用。 | ||||||
| 9 | 杂环发色团结构 | CN200580036669.5 | 2005-10-26 | CN101048390A | 2007-10-03 | F·J·戈茨; F·J·小戈茨 |
| 式I的NLO发色团及其工业上可接受的盐、溶剂化物和水合物，其中Z1－4、X1－4、π1－2、D和A具有本文提供的定义。 | ||||||
| 10 | Herbicidal (2-imidazolin-2-yl) condensed heterocyclic pyridine compounds | JP29505686 | 1986-12-12 | JPH07116185B2 | 1995-12-13 | ジエリイ・リー・ジヨンソン; ジヨン・マイケル・フイン; シン−シオン・ツエン; デビツド・ウイリアム・ラドナー; バリントン・クロス; ピーター・ジヨン・ウエツプロ; ビクター・マルク・カミ; マイケル・イー・ジヤング; マリナス・ロス; ロバート・フランシス・デーナー・ジユニア |
| 11 | JPH01501866A - | JP50133688 | 1987-12-28 | JPH01501866A | 1989-06-29 | |
| 12 | Novel carbamoyloxylabdanes | JP33033387 | 1987-12-28 | JPS63185974A | 1988-08-01 | REIMONDO UOORUTAA KOSURII JIYU; ROBAATO JIYOZEFU CHIERIRU |
| 13 | Herbicidal (2-imidazoline-2-yl) fused heteropyridine compound | JP29505686 | 1986-12-12 | JPS62175480A | 1987-08-01 | BARINTON KUROSU; MARINASU ROSU; ROBAATO FURANSHISU DEENAA JIYU; DEBITSUDO UIRIAMU RADONAA; JIERII RII JIYONSON; MAIKERU II JIYANGU; BIKUTAA MARUKU KAMI; SHINNSHION TSUEN; JIYON MAIKERU FUIN; PIITAA JIYON UETSUPURO |
| 14 | 化合物、高分子化合物、酸発生剤、レジスト組成物、レジストパターン形成方法 | JP2011094450 | 2011-04-20 | JP5732306B2 | 2015-06-10 | 小室 嘉崇; 内海 義之; 川上 晃也; 新井 雅俊 |
| 15 | Compound, polymer compound, acid generator, resist composition, and method for forming resist pattern | JP2011094450 | 2011-04-20 | JP2012224586A | 2012-11-15 | KOMURO YOSHITAKA; UTSUMI YOSHIYUKI; KAWAKAMI AKINARI; ARAI MASATOSHI |
| PROBLEM TO BE SOLVED: To provide a new compound, a polymer compound, a resist composition, an acid generator and a method for forming a resist pattern.SOLUTION: The compound is represented by general formula (1-1) (wherein, each of Rand Rindependently represents a single bond or a divalent linking group; A represents a divalent linking group; each of Rand Rindependently represents a hydroxy group, a hydrocarbon group which may have a substituent, or a group represented by general formula (1-an1), (1-an2) or (1-an3); n0 is 0 or 1; Yrepresents a single bond or -SO-; Rrepresents a monovalent hydrocarbon group of 1 to 10 carbon atoms, a cyclic monovalent hydrocarbon group of 3 to 20 carbon atoms, or a monovalent hydrocarbon group of 3 to 20 carbon atoms having a cyclic partial structure, which may be substituted with a fluorine atom; and Mrepresents an organic cation or a metal cation). | ||||||
| 16 | Fused polythiophene-s,s-dioxide and method for producing the same | JP2005067756 | 2005-03-10 | JP2006248983A | 2006-09-21 | YAMAGUCHI SHIGEHIRO; OKAMOTO TOSHIHIRO |
| PROBLEM TO BE SOLVED: To provide a fused polythiophene-S,S-dioxide having not only high electron-accepting ability but also an π-conjugated skeleton in high flatness. SOLUTION: The fused polythiophene-S,S-dioxide is obtained by oxidizing at least one sulfur included in a fused polythiophene represented by formula (1a) or (1b) (wherein, R is one kind selected from hydrogen, a trialkylsilyl group, a 1-18C alkyl group, a fluoroalkyl group that is a 1-18C alkyl group in which the whole or a part of hydrogens are substituted with fluorines, and the like; and n is an integer) into dioxide. COPYRIGHT: (C)2006,JPO&NCIPI | ||||||
| 17 | Novel compound | JP2001511449 | 2000-07-20 | JP2003505388A | 2003-02-12 | アールフ・クラーソン; オード・イェイル・ベルイェ; ブリト・マーリー・スワーン |
| (57)【要約】 本発明は良好な鎮痛活性を示しそして慢性痛の治療に特に有効である式Ｉのあるスピロオキシインドール誘導体、及びそれらの医薬的に許容し得る塩に関する。 【化１】 | ||||||
| 18 | 벤조 티오펜 유도체의 제조 방법 | KR1019810002182 | 1981-06-16 | KR1019830006301A | 1983-09-20 | 다무라야스미쓰외5인 |
| 내용없음 | ||||||
| 19 | HETEROARYL SUBSTITUTED QUINOLIN-4-YLAMINE ANALOGUES | PCT/US2006001345 | 2006-01-13 | WO2006076646A3 | 2006-08-17 | CALDWELL TIMOTHY M; CHENARD BERTRAND; HODGETTS KEVIN |
| Heteroaryl substituted quinolin-4-ylamine analogues of Formula (I) are provided. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies. | ||||||
| 20 | IMIDAZO{4,5-B}PYRAZINONE INHIBITORS OF PROTEIN KINASES | PCT/US2005034395 | 2005-09-23 | WO2006036883A3 | 2006-06-22 | LIU JIAN; PATCH RAYMOND J; PLAYER MARK R |
| The invention is directed to compounds of Formula (I): Wherein Q, Y, A are set forth in the specification, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, that inhibit protein kinases, especially Aurora-1, Aurora-2 and Aurora-3 kinases. | ||||||
QQ群二维码
意见反馈
意见反馈